Kayne Anderson Rudnick Investment Management
TMCI icon

Kayne Anderson Rudnick Investment Management’s Treace Medical Concepts TMCI Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-777,373
Closed -$20.9M – 657
2021
Q3 		$20.9M Buy
777,373
+6,109
+0.8% +$168K 0.05% 188
2021
Q2 		$24.1M Buy
+771,264
New +$24.5M 0.06% 183

Other funds holding TMCI

CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's TMCI Position: Q4 2021 in Review

Kayne Anderson Rudnick Investment Management sold out of Treace Medical Concepts (TMCI) in Q4 2021, closing a stake of 777,373 shares — an estimated $20.9M sold.

Kayne Anderson Rudnick Investment Management first reported a position in TMCI in Q2 2021 and held it in 2 quarters. The position peaked at $24.1M in Q2 2021. 77 funds tracked by Wall St. Rank hold TMCI as of Q4 2021.

  • Kayne Anderson Rudnick Investment Management reported no remaining Treace Medical Concepts position as of Q4 2021 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 777,373 Treace Medical Concepts shares in Q4 2021, an estimated $20.9M.
  • Kayne Anderson Rudnick Investment Management first reported a position in Treace Medical Concepts in Q2 2021 and held it in 2 quarters.
  • Kayne Anderson Rudnick Investment Management's Treace Medical Concepts position peaked at $24.1M in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2021.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.